Clinical Research Blog Archives - Page 6 of 11

Interview with Amy O'Sullivan of SCOPE International

To Succeed with Virtual or Hybrid Clinical Trials, Listen to Patients and Sites

We recently spoke about virtual and hybrid clinical trials with Amy O’Sullivan, Director of North American Operations at SCOPE International, an independent full-service CRO serving pharma, biotech, and medical device clients across the US and Europe. The company is headquartered in Mannheim, Germany, with US operations based in Pittsburgh, PA.

Posted on 10 Dec 2020
By ArcheMedX Team
In Clinical Research Blog, Interviews

How CROs Can Help Sponsors with Clinical Trial Readiness

4 Ways CROs Can Help Sponsors with Clinical Trial Readiness

When a Sponsor chooses to engage with a contract research organization (CRO), the Sponsor team expects quality and performance in return for their investment. CROs are in business to conduct trials - and offload the work from the Sponsor’s side. So why are so many trials fraught with early hiccups? The

Posted on 20 Nov 2020
By ArcheMedX Team
In Clinical Research Blog

Conversations in Clinical Trial Readiness: Kunal Sampat of Ceribell

Kunal Sampat joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the changing landscape of clinical trial operations. An experienced Clinical Operations Director, Kunal shares his key learnings from 2020 and elaborates on some of the successes and challenges he’s seen this year. Industry stakeholders

Posted on 17 Nov 2020
By ArcheMedX Team
In Clinical Research Blog, Interviews

SCOPE Clinical Innovations Summit with ArcheMedX

Clinical Innovations Summit has gone virtual in 2020 – join us there!

Most, if not all, industry events have gone virtual in 2020. Clinical Innovations Summit is the most recent one to convert to an online setting, and it's now combined with SCOPE Europe, usually held in beautiful Barcelona, Spain. The ArcheMedX team is excited to be a cornerstone of this year's Clinical

Posted on 22 Oct 2020
By ArcheMedX Team
In Clinical Research Blog

Women of Color in Pharma Launches “Ally is a Verb” Learning Activity with ArcheMedX

Women of Color in Pharma (WOCIP) has emerged as a leading organization teaching our industry how to empower women of color through bold action. Their value to all of us is best explained in their “Our Why” statement, where they commit to “Creating a nurturing and safe environment for self-reflection and

Posted on 7 Oct 2020
By ArcheMedX Team
In Clinical Research Blog, News

The Virtual Clinical Trial Start-Up: How to Make It Work

Making it through the clinical trial start-up process is critical for any study - and takes a lot of effort under normal circumstances. But today, with the need to conduct more and more clinical operations remotely - it’s even more challenging. The good news is that there is a way forward,

Posted on 9 Sep 2020
By ArcheMedX Team
In Clinical Research Blog

092020_Study_Start-Up_Is_the_Latest_Virtual_Priority_in_Clinical_Trials

Survey Reveals that Study Start-Up is the Latest Target in the March to Virtual Clinical Trials

6 months after COVID-19 hit, one trend has emerged as a dominant theme: making virtual clinical trials a reality. Catch up on the recent survey data.

Posted on 1 Sep 2020
By ArcheMedX Team
In Clinical Research Blog

Running a Virtual Investigator Meeting in 4 Steps

If you’re going to start a clinical trial in the post-COVID area, a virtual investigator meeting needs to be in your plans. Here’s how to do it.

Posted on 11 Aug 2020
By ArcheMedX Team
In Clinical Research Blog

Mike McLaughlin -innovation in clinical trials

Interview: Start-Up Phase is a Prime Target for Virtual Activities in Clinical Trials, So Let’s Adapt

Before 2020 “virtual clinical trials” was just a buzzword. Now we’re forced to adapt. But what challenges – and opportunities – are ahead?

Posted on 11 Aug 2020
By ArcheMedX Team
In Clinical Research Blog, Interviews

Stop guessing to reduce clinical trial delays

Guessing could be adding 7 months of clinical trial delays. Here’s how to stop.

Getting new treatments approved has never been harder, but recent research reveals that the regulatory agency has also never been faster. So why is it getting more expensive and taking ever longer to bring a treatment to market? Three words: Clinical trial delays. It’s taking longer to bring a treatment to

Posted on 31 Jul 2020
By ArcheMedX Team
In Clinical Research Blog

Clinical Operations

Commercial Teams

Resources

Medical Education

About Us

Connect with us

Category : Clinical Research Blog

To Succeed with Virtual or Hybrid Clinical Trials, Listen to Patients and Sites

4 Ways CROs Can Help Sponsors with Clinical Trial Readiness

Conversations in Clinical Trial Readiness: Kunal Sampat of Ceribell

Clinical Innovations Summit has gone virtual in 2020 – join us there!

Women of Color in Pharma Launches “Ally is a Verb” Learning Activity with ArcheMedX

The Virtual Clinical Trial Start-Up: How to Make It Work

Survey Reveals that Study Start-Up is the Latest Target in the March to Virtual Clinical Trials

Running a Virtual Investigator Meeting in 4 Steps

Interview: Start-Up Phase is a Prime Target for Virtual Activities in Clinical Trials, So Let’s Adapt

Guessing could be adding 7 months of clinical trial delays. Here’s how to stop.

Social

Recent News

ArcheMedX Releases Largest Confidence-Based Assessment Dataset in CNS Clinical Research at CNS Summit 2025

The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous

Contact Us

300 E Main Street, Suite 101 Charlottesville, VA 22902

+1-434-260-1850

Email Us

About Us

Subscribe

Request a Demo